Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
1.420
-0.060 (-4.05%)
Nov 4, 2024, 4:00 PM EST - Market closed

Nephros Statistics

Total Valuation

Nephros has a market cap or net worth of $14.97 million. The enterprise value is $13.47 million.

Market Cap 14.97M
Enterprise Value 13.47M

Important Dates

The next confirmed earnings date is Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

Nephros has 10.54 million shares outstanding. The number of shares has increased by 1.72% in one year.

Shares Outstanding 10.54M
Shares Change (YoY) +1.72%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 12.34%
Owned by Institutions (%) 6.83%
Float 5.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.08
Forward PS 1.88
PB Ratio 1.89
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.98
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.20.

Current Ratio 4.06
Quick Ratio 2.54
Debt / Equity 0.20
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -684.50

Financial Efficiency

Return on equity (ROE) is -15.61% and return on invested capital (ROIC) is -9.00%.

Return on Equity (ROE) -15.61%
Return on Assets (ROA) -7.96%
Return on Capital (ROIC) -9.00%
Revenue Per Employee $444,194
Profits Per Employee -$41,742
Employee Count 31
Asset Turnover 1.28
Inventory Turnover 2.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -12.88% in the last 52 weeks. The beta is 1.19, so Nephros's price volatility has been higher than the market average.

Beta (5Y) 1.19
52-Week Price Change -12.88%
50-Day Moving Average 1.65
200-Day Moving Average 2.24
Relative Strength Index (RSI) 36.02
Average Volume (20 Days) 9,935

Short Selling Information

The latest short interest is 626, so 0.01% of the outstanding shares have been sold short.

Short Interest 626
Short Previous Month 2,567
Short % of Shares Out 0.01%
Short % of Float 0.01%
Short Ratio (days to cover) 0.04

Income Statement

In the last 12 months, Nephros had revenue of $13.77 million and -$1.29 million in losses. Loss per share was -$0.12.

Revenue 13.77M
Gross Profit 8.31M
Operating Income -1.37M
Pretax Income -1.29M
Net Income -1.29M
EBITDA -1.19M
EBIT -1.37M
Loss Per Share -$0.12
Full Income Statement

Balance Sheet

The company has $3.08 million in cash and $1.58 million in debt, giving a net cash position of $1.50 million or $0.14 per share.

Cash & Cash Equivalents 3.08M
Total Debt 1.58M
Net Cash 1.50M
Net Cash Per Share $0.14
Equity (Book Value) 7.93M
Book Value Per Share 0.75
Working Capital 5.97M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$848,000 and capital expenditures -$130,000, giving a free cash flow of -$978,000.

Operating Cash Flow -848,000
Capital Expenditures -130,000
Free Cash Flow -978,000
FCF Per Share -$0.09
Full Cash Flow Statement

Margins

Gross margin is 60.38%, with operating and profit margins of -9.94% and -9.40%.

Gross Margin 60.38%
Operating Margin -9.94%
Pretax Margin -9.40%
Profit Margin -9.40%
EBITDA Margin -8.66%
EBIT Margin -9.94%
FCF Margin -6.70%

Dividends & Yields

Nephros does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.72%
Shareholder Yield -1.72%
Earnings Yield -8.64%
FCF Yield -6.53%

Analyst Forecast

The average price target for Nephros is $5.00, which is 252.11% higher than the current price. The consensus rating is "Buy".

Price Target $5.00
Price Target Difference 252.11%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date Jul 10, 2019
Split Type Reverse
Split Ratio 0.1111111:1

Scores

Nephros has an Altman Z-Score of -12.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -12.34
Piotroski F-Score 3